These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 19399787

  • 1. Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.
    Karsenty G, Rocha J, Chevalier S, Scarlata E, Andrieu C, Zouanat FZ, Rocchi P, Giusiano S, Elzayat EA, Corcos J.
    Prostate; 2009 Aug 01; 69(11):1143-50. PubMed ID: 19399787
    [Abstract] [Full Text] [Related]

  • 2. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 3. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
    Srivastava SK, Xiao D, Lew KL, Hershberger P, Kokkinakis DM, Johnson CS, Trump DL, Singh SV.
    Carcinogenesis; 2003 Oct 01; 24(10):1665-70. PubMed ID: 12896904
    [Abstract] [Full Text] [Related]

  • 4. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

  • 5. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Peternac D, Klima I, Cecchini MG, Schwaninger R, Studer UE, Thalmann GN.
    Prostate; 2008 Sep 01; 68(12):1307-18. PubMed ID: 18512728
    [Abstract] [Full Text] [Related]

  • 6. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
    Choi MS, Oh JH, Kim SM, Jung HY, Yoo HS, Lee YM, Moon DC, Han SB, Hong JT.
    Int J Oncol; 2009 May 01; 34(5):1221-30. PubMed ID: 19360335
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2284-9. PubMed ID: 19080333
    [Abstract] [Full Text] [Related]

  • 8. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
    Sinha AA, Quast BJ, Reddy PK, Elson MK, Wilson MJ.
    Anticancer Res; 1999 Nov 20; 19(2A):893-902. PubMed ID: 10368631
    [Abstract] [Full Text] [Related]

  • 9. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ.
    Prostate; 2004 Mar 01; 58(4):382-93. PubMed ID: 14968439
    [Abstract] [Full Text] [Related]

  • 10. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
    Sánchez AM, Sánchez MG, Malagarie-Cazenave S, Olea N, Díaz-Laviada I.
    Apoptosis; 2006 Jan 01; 11(1):89-99. PubMed ID: 16374544
    [Abstract] [Full Text] [Related]

  • 11. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S, Lee J, Revelo M, Wang X, Lu S, Dong Z.
    Clin Cancer Res; 2007 Oct 01; 13(19):5692-702. PubMed ID: 17908958
    [Abstract] [Full Text] [Related]

  • 12. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E, Schally AV, Buchholz S, Rick FG, Halmos G, Mile M, Groot K, Hohla F, Zarandi M, Varga JL.
    Prostate; 2008 Dec 01; 68(16):1763-72. PubMed ID: 18729085
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts.
    Rice L, Samedi VG, Medrano TA, Sweeney CA, Baker HV, Stenstrom A, Furman J, Shiverick KT.
    Prostate; 2002 Aug 01; 52(3):201-12. PubMed ID: 12111696
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
    Udayakumar TS, Bair EL, Nagle RB, Bowden GT.
    Mol Carcinog; 2003 Oct 01; 38(2):70-7. PubMed ID: 14502646
    [Abstract] [Full Text] [Related]

  • 15. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice.
    Smith PC, Keller ET.
    Prostate; 2001 Jun 15; 48(1):47-53. PubMed ID: 11391686
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Is botulinum toxin type a intraprostatic injections really effective in patients with urinary retention?
    Jasiński M, Drewa T, Tyloch J, Wolski Z.
    Acta Pol Pharm; 2011 Jun 15; 68(5):765-8. PubMed ID: 21928723
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.